D-K6L9

General Information


DRACP ID  DRACP00157

Peptide Name   D-K6L9

Sequence  LKlLKKLlkKLLkLL

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Host Defense lytic Peptide

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
22Rv1 Prostate carcinoma Carcinoma LC50=6 μmol/L ELISA assay Not available 1
CL-1 Canine leukemia Leukemia LC50=3 μmol/L ELISA assay Not available 1
MDA-MB-231 Breast adenocarcinoma Carcinoma LC50=3 μmol/L ELISA assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  surface phosphatidylserine

Affinity  Not available

Mechanism  The exclusive selectivity of the peptide towards cancer derives from its specific binding to surface phosphatidylserine and the killing of the cancer cells via cytoplasmic membrane depolarization

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  l=D-Leucine; k=D-Lysine

Chiral  Mix



Physicochemical Information


Formula  C66H119N15O8

Absent amino acids  ACDEFGHIMNPQRSTVWY

Common amino acids  L

Mass  150068

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  7

Net charge  4

Boman Index  1224

Hydrophobicity  73.33

Aliphatic Index  182

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16707464

Title  Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide

Doi 10.1158/0008-5472.CAN-05-4569

Year  2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.